Featured Stories

NYMC Administers First Novel Inhaled mRNA Therapy for Cystic Fibrosis in the U.S.

The First Dose of RCT2100 was Successfully Administered to a Patient with Cystic Fibrosis

New York Medical College (NYMC), in collaboration with ReCode Therapeutics, a clinical-stage genetic medicines company, administered the first U.S. dose of RCT2100 — a novel investigational inhaled messenger RNA (mRNA) therapy for people with cystic fibrosis (CF). The clinical trial, which will assess the safety and tolerability of RCT2100, will provide new hope for people who do not respond to existing CFTR modulator treatments. While there are currently 13 clinical trial sites for RCT2100 throughout the country, this was the first dose to be successfully administered in the United States.

Stories

Ask the big questions. Be part of important conversations. Touro sponsors the Forum on Life, Culture & Society (FOLCS) which uses the arts as a catalyst for conversation and as a tool to re-examine the status quo, so we can develop ideas and together help build a better world. Join us!

Visit FOLCS
FOLCS live event

Publications

The President's Report is our signature publication, spotlighting innovation, new initiatives, ground-breaking research and high achieving Touro students, faculty and alumni. You can view many of Touro's other publications on Touro Scholar. Touro University Press publishes scholarly works on the entire range of the liberal arts and sciences, with special attention to the areas of Jewish history and literature.

Touro Events

Jan 13January 13, 2025 5:00pm ETSonography Program Virtual Open House

Machon L'Parnasa

Jan 13January 13, 2025 6:30pm – 7:30pm ETBS/MS Occupational Therapy Information Session (Virtual)

School of Health Sciences

Jan 14January 14, 2025 6:30pm ETSpeech-Language Pathology Open House

School of Health Sciences

Jan 14January 14, 2025 6:30pm – 7:30pm ETDoctor of Physical Therapy Information Session (Virtual)

School of Health Sciences

Around Touro

    Media Contacts

    Ellie Schlam

    Executive Director of Communications and Marketing

    (646) 565-6420

    Barbara Franklin

    Director of Communications

    (646) 565-6531